Home/Filings/4/0000939767-25-000045
4//SEC Filing

Smith Julie 4

Accession 0000939767-25-000045

CIK 0000939767other

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 8:35 PM ET

Size

17.6 KB

Accession

0000939767-25-000045

Insider Transaction Report

Form 4
Period: 2025-02-27
Smith Julie
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2025-02-27$19.77/sh+23,347$461,57065,292 total
  • Exercise/Conversion

    Option (right to buy)

    2025-02-2723,34719,294 total
    Exercise: $19.77From: 2019-05-23Exp: 2026-05-22Common Stock (23,347 underlying)
  • Exercise/Conversion

    Option (right to buy)

    2025-02-2819,2940 total
    Exercise: $19.77From: 2019-05-23Exp: 2026-05-22Common Stock (19,294 underlying)
  • Exercise/Conversion

    Common Stock

    2025-02-27$20.50/sh+31,167$638,92441,945 total
  • Sale

    Common Stock

    2025-02-27$38.13/sh54,514$2,078,61910,778 total
  • Exercise/Conversion

    Common Stock

    2025-02-28$19.77/sh+19,294$381,44230,072 total
  • Sale

    Common Stock

    2025-02-28$37.62/sh19,294$725,84010,778 total
  • Exercise/Conversion

    Option (right to buy)

    2025-02-2731,1670 total
    Exercise: $20.50From: 2018-05-24Exp: 2025-05-23Common Stock (31,167 underlying)
Footnotes (4)
  • [F1]Includes 10,015 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
  • [F2]Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $37.75 to $38.37. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
  • [F3]The option, representing the right to purchase a total of 31,167 shares of Common Stock, became fully exercisable on May 24, 2018.
  • [F4]The option, representing the right to purchase a total of 42,641 shares of Common Stock, became fully exercisable on May 23, 2019.

Issuer

EXELIXIS, INC.

CIK 0000939767

Entity typeother

Related Parties

1
  • filerCIK 0001557928

Filing Metadata

Form type
4
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 8:35 PM ET
Size
17.6 KB